IHH Healthcare Set for Sustained Growth, Backed by Expansion Plans -- Market Talk

Dow Jones

2025/05/30

0105 GMT - IHH Healthcare is poised for continued growth, supported by a planned 28% increase in hospital bed capacity by 2028, mainly in Malaysia and India, Hong Leong IB analyst Chee Kok Siang says in a note. In Singapore and Hong Kong, IHH plans to expand across the care continuum with a focus on ambulatory and primary care, while also aiming to turn around its China operations, he says. Ongoing refurbishments at Singapore's Mount Elizabeth Hospital at Orchard may pressure margins until 2Q, he adds. Management remains open to merger-and-acquisition opportunities, targeting value-accretive assets in Malaysia, India, Turkey, and Europe, he notes. Hong Leong raises IHH's target price to MYR9.06 from MYR9.03 while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR6.86.(yingxian.wong@wsj.com)

(END) Dow Jones Newswires

May 29, 2025 21:05 ET (01:05 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2539906002"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2539906002\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2539906002?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-30 09:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2539906002","market":"fut","top_or_hot":-1,"title":"IHH Healthcare Set for Sustained Growth, Backed by Expansion Plans -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0105 GMT - IHH Healthcare is poised for continued growth, supported by a planned 28% increase in hospital bed capacity by 2028, mainly in Malaysia and India, Hong Leong IB analyst Chee Kok Siang says in a note. In Singapore and Hong Kong, IHH plans to expand across the care continuum with a focus on ambulatory and primary care, while also aiming to turn around its China operations, he says. Ongoing refurbishments at Singapore's Mount Elizabeth Hospital at Orchard may pressure margins until 2Q, he adds. Management remains open to merger-and-acquisition opportunities, targeting value-accretive assets in Malaysia, India, Turkey, and Europe, he notes. Hong Leong raises IHH's target price to MYR9.06 from MYR9.03 while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR6.86.(yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 29, 2025 21:05 ET (01:05 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IHH Healthcare Set for Sustained Growth, Backed by Expansion Plans -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIHH Healthcare Set for Sustained Growth, Backed by Expansion Plans -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-05-30 09:05</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0105 GMT - IHH Healthcare is poised for continued growth, supported by a planned 28% increase in hospital bed capacity by 2028, mainly in Malaysia and India, Hong Leong IB analyst Chee Kok Siang says in a note. In Singapore and Hong Kong, IHH plans to expand across the care continuum with a focus on ambulatory and primary care, while also aiming to turn around its China operations, he says. Ongoing refurbishments at Singapore's Mount Elizabeth Hospital at Orchard may pressure margins until 2Q, he adds. Management remains open to merger-and-acquisition opportunities, targeting value-accretive assets in Malaysia, India, Turkey, and Europe, he notes. Hong Leong raises IHH's target price to MYR9.06 from MYR9.03 while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR6.86.(yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 29, 2025 21:05 ET (01:05 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCSG","symbol_name":"Healthcare Svcs Group Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2539906002","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2539906002","pubTimestamp":1748567100,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0105 GMT - IHH Healthcare is poised for continued growth, supported by a planned 28% increase in hospital bed capacity by 2028, mainly in Malaysia and India, Hong Leong IB analyst Chee Kok Siang says in a note. In Singapore and Hong Kong, IHH plans to expand across the care continuum with a focus on ambulatory and primary care, while also aiming to turn around its China operations, he says. Ongoing refurbishments at Singapore's Mount Elizabeth Hospital at Orchard may pressure margins until 2Q, he adds. Management remains open to merger-and-acquisition opportunities, targeting value-accretive assets in Malaysia, India, Turkey, and Europe, he notes. Hong Leong raises IHH's target price to MYR9.06 from MYR9.03 while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR6.86.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HCSG":"Healthcare Svcs Group Inc","BK4137":"综合支持服务","BK6511":"医疗保健服务概念","BK6092":"保健护理机构","Q0F.SI":"IHH医疗保健集团"},"translate_title":"IHH Healthcare在扩张计划的支持下将持续增长——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1,"Q0F.SI":0.9},"content_text":"0105 GMT - IHH Healthcare is poised for continued growth, supported by a planned 28% increase in hospital bed capacity by 2028, mainly in Malaysia and India, Hong Leong IB analyst Chee Kok Siang says in a note. In Singapore and Hong Kong, IHH plans to expand across the care continuum with a focus on ambulatory and primary care, while also aiming to turn around its China operations, he says. Ongoing refurbishments at Singapore's Mount Elizabeth Hospital at Orchard may pressure margins until 2Q, he adds. Management remains open to merger-and-acquisition opportunities, targeting value-accretive assets in Malaysia, India, Turkey, and Europe, he notes. Hong Leong raises IHH's target price to MYR9.06 from MYR9.03 while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR6.86.(yingxian.wong@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 29, 2025 21:05 ET (01:05 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}